Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients

Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients

Source: 
Yahoo/Reuters
snippet: 

Nektar Therapeutics said on Friday some patients with advanced bladder cancer treated with a combination of its experimental treatment and Bristol-Myers Squibb Co's immunotherapy, Opdivo, showed signs of tumor reduction in an early-stage study.